Cargando…

Fascaplysin Exerts Anti-Cancer Effects through the Downregulation of Survivin and HIF-1α and Inhibition of VEGFR2 and TRKA

Fascaplysin has been reported to exert anti-cancer effects by inhibiting cyclin-dependent kinase 4 (CDK4); however, the precise mode of action by which fascaplysin suppresses tumor growth is not clear. Here, we found that fascaplysin has stronger anti-cancer effects than other CDK4 inhibitors, inclu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Taek-In, Lee, Yoon-Mi, Nam, Taek-Jin, Ko, Young-San, Mah, Shinmee, Kim, Jinhee, Kim, Younghoon, Reddy, Rallabandi Harikrishna, Kim, Young Jun, Hong, Sungwoo, Lim, Ji-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5666756/ https://www.ncbi.nlm.nih.gov/pubmed/28961193 http://dx.doi.org/10.3390/ijms18102074

Ejemplares similares

Fascaplysin Sensitizes Anti-Cancer Effects of Drugs Targeting AKT and AMPK
por: Oh, Taek-In, et al.
Publicado: (2017)

The Marine-Derived Kinase Inhibitor Fascaplysin Exerts Anti-Thrombotic Activity
por: Ampofo, Emmanuel, et al.
Publicado: (2015)

HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis
por: Park, Han-Hee, et al.
Publicado: (2018)

Targeting the C-Terminal Domain Small Phosphatase 1
por: Rallabandi, Harikrishna Reddy, et al.
Publicado: (2020)

Research Trends in C-Terminal Domain Nuclear Envelope Phosphatase 1
por: Rallabandi, Harikrishna Reddy, et al.
Publicado: (2023)

FASCAPLYSIN as a Specific Inhibitor for CDK4: Insights from Molecular Modelling
por: Shafiq, Muhammad Imtiaz, et al.
Publicado: (2012)

Cytotoxic Effects of Fascaplysin against Small Cell Lung Cancer Cell Lines
por: Hamilton, Gerhard
Publicado: (2014)

Total Syntheses and Preliminary Biological Evaluation of Brominated Fascaplysin and Reticulatine Alkaloids and Their Analogues
por: Zhidkov, Maxim E., et al.
Publicado: (2019)

Marine-Derived Lead Fascaplysin: Pharmacological Activity, Total Synthesis, and Structural Modification
por: Wang, Chao, et al.
Publicado: (2023)

Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner
por: Sui, Tongtong, et al.
Publicado: (2021)

NGF Prevents Loss of TrkA/VEGFR2 Cells, and VEGF Isoform Dysregulation in the Retina of Adult Diabetic Rats
por: Fico, Elena, et al.
Publicado: (2022)

TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023)

A pyrone remodeling strategy to access diverse heterocycles: application to the synthesis of fascaplysin natural products
por: Palani, Vignesh, et al.
Publicado: (2020)

Study of Structure–Activity Relationships of the Marine Alkaloid Fascaplysin and Its Derivatives as Potent Anticancer Agents
por: Zhidkov, Maxim E., et al.
Publicado: (2022)

A New Mild Method for Synthesis of Marine Alkaloid Fascaplysin and Its Therapeutically Promising Derivatives
por: Tryapkin, Oleg A., et al.
Publicado: (2023)

Cytoplasmic TrkA Expression as a Screen for Detecting NTRK1 Fusions in Colorectal Cancer()()
por: Choi, Yuri, et al.
Publicado: (2018)

Diterpene Ginkgolides Exert an Antidepressant Effect Through the NT3-TrkA and Ras-MAPK Pathways
por: Wang, Ting, et al.
Publicado: (2020)

Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression
por: Kim, Young A, et al.
Publicado: (2012)

MicroRNAs Targeting HIF-2α, VEGFR1 and/or VEGFR2 as Potential Predictive Biomarkers for VEGFR Tyrosine Kinase and HIF-2α Inhibitors in Metastatic Clear-Cell Renal Cell Carcinoma
por: Kinget, Lisa, et al.
Publicado: (2021)

Downregulation of survivin expression exerts antitumoral effects on mouse breast cancer cells in vitro and in vivo
por: MA, WEN-HUI, et al.
Publicado: (2016)

β-Lapachone Exerts Anticancer Effects by Downregulating p53, Lys-Acetylated Proteins, TrkA, p38 MAPK, SOD1, Caspase-2, CD44 and NPM in Oxaliplatin-Resistant HCT116 Colorectal Cancer Cells
por: Jung, Eun Joo, et al.
Publicado: (2023)

Asymmetric C–H functionalization of cyclopropanes using an isoleucine-NH(2) bidentate directing group
por: Kim, Jinhee, et al.
Publicado: (2015)

Characterization of KRC-108 as a TrkA Kinase Inhibitor with Anti-Tumor Effects
por: Lee, Hyo Jeong, et al.
Publicado: (2022)

Survivin expression and its clinical significance in pancreatic cancer
por: Lee, Myung Ah, et al.
Publicado: (2005)

Anticancer Activity of Fascaplysin against Lung Cancer Cell and Small Cell Lung Cancer Circulating Tumor Cell Lines
por: Rath, Barbara, et al.
Publicado: (2018)

Alkaloids of fascaplysin are effective conventional chemotherapeutic drugs, inhibiting the proliferation of C6 glioma cells and causing their death in vitro
por: Bryukhovetskiy, Igor, et al.
Publicado: (2017)

Comparison of the Inhibitory Binding Modes Between the Planar Fascaplysin and Its Nonplanar Tetrahydro-β-carboline Analogs in CDK4
por: Liang, Yan, et al.
Publicado: (2021)

VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis
por: Jang, Jeon Yeob, et al.
Publicado: (2017)

NGF Causes TrkA to Specifically Attract Microtubules to Lipid Rafts
por: Pryor, Shona, et al.
Publicado: (2012)

Synergistic cytotoxicity of the CDK4 inhibitor Fascaplysin in combination with EGFR inhibitor Afatinib against Non-small Cell Lung Cancer
por: Plangger, Adelina, et al.
Publicado: (2021)

Selective inhibition of histone deacetylase 2 induces p53-dependent survivin downregulation through MDM2 proteasomal degradation
por: Seo, Sung-Keum, et al.
Publicado: (2014)

HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression
por: Harashima, Nanae, et al.
Publicado: (2017)

NGF – the TrkA to successful pain treatment
por: Kumar, Vinayak, et al.
Publicado: (2012)

Characterization of TRKA signaling in acute myeloid leukemia
por: Herbrich, Shelley M., et al.
Publicado: (2018)

Effect of Botulinum Toxin Injection on Asymmetric Lower Face with Chin Deviation
por: Kim, Dongwook, et al.
Publicado: (2020)

Capsosiphon fulvescens glycoprotein inhibits AGS gastric cancer cell proliferation by downregulating Wnt-1 signaling
por: KIM, YOUNG-MIN, et al.
Publicado: (2013)

Low-dose metronomic doxorubicin inhibits mobilization and differentiation of endothelial progenitor cells through REDD1-mediated VEGFR-2 downregulation
por: Park, Minsik, et al.
Publicado: (2021)

Thymoquinone Selectively Kills Hypoxic Renal Cancer Cells by Suppressing HIF-1α-Mediated Glycolysis
por: Lee, Yoon-Mi, et al.
Publicado: (2019)

Prognostic Significance of Nuclear Survivin Expression in Resected Adenoid Cystic Carcinoma of the Head and Neck
por: Ko, Yoon Ho, et al.
Publicado: (2010)

Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality
por: Kim, Il-Kug, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ifpja8i3ms61aejdu8p5onjtgn